Q2 STOCKS TO BUY

Bullish Bias Grows on Immunotherapy Stock

Not only are analysts bullish, but call buying has been popular

Mar 28, 2019 at 9:21 AM
facebook X logo linkedin


The shares of immunotherapy stock Affimed NV (NASDAQ:AFMD) saw a small pop on Wednesday following the company's full-year 2018 financial report. Analysts at BMO were impressed enough to lift their price target to $7 from $6, and SVB Leerink began coverage on the healthcare concern with an "outperform" designation and $8 price target.

Such attention from the brokerage crowd is nothing new for AFMD stock. In fact, all four of the firms covering the equity already had "strong buy" recommendations, and the average 12-month price target is $8.17 -- showing the consensus view is that the shares could roughly double from yesterday's close of $4.17.

There's also been a notable build-up in bullish bets from the options crowd. Data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows 977 calls purchased in the last 10 days, compared to three puts. The May 5 call saw the largest increase in open interest, followed by the July 5 call. Taking a broader view, peak open interest resides at the front-month April 5 call, where 5,243 positions are open.

At last check, the security was set to open up 5%. Back in August, the shares exploded to $7.35 for a brief moment, but quickly gave back those gains, entering 2019 at $3.11 following a strong December bounce from the 200-day moving average. Since then, Affimed stock has been grinding higher, enjoying consistent support from the 20-day moving average.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter